Short-term Clinical Study of CN128 in Thalassemia Patients
NCT03935633
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Thalassemia
Interventions
DRUG:
CN128 Tablets
Sponsor
Hangzhou Zede Pharma-Tech Co., Ltd.